Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication
Yoshinori Ishikawa(Takeda (Japan)), Kazuhide Nakamura(Takeda (Japan))
Cited by 38
Related Papers
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth
|Molecular Cancer Therapeutics|2004|66